Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 2 14Phase 3 7Phase 1 5Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Tea × Clear all
NCT06615752 2026-04-15

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Charles Drew University of Medicine and Science

Phase 1/2 Recruiting
99 enrolled
Genitourinary

Prostatic Neoplasms

NCT06875791 2025-04-01

TEMOR

Fundacion Clinica Valle del Lili

Phase 1/2 Not yet recruiting
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡